Home Tags Perceptive Xontogeny Venture Fund

Perceptive Xontogeny Venture Fund

Marea Therapeutics, a clinical-stage biotechnology company has secured $190M combined Series A and B Funding. The Series A round was led by Third Rock Ventures and the Series B round was led by Sofinnova Investments and co-led by Forbion, Perceptive Xontogeny Venture Fund and venBio, with the participation of Alpha Wave Global, Omega Funds, Surveyor Capital and founding investor Third Rock Ventures.

[Funding News] CA-based Marea Therapeutics Raises $190M Funding

Team SR -
© Copyright startuprise 2024 All Rights Reserved.
Exit mobile version